Inspiration Mining Corporation

  • ISIN: CA45772J2083
  • Land: .

Nachricht vom 11.01.2018 | 16:00

Inspiration Enters into Negotiations to AcquireCompassion Cannabis

DGAP-News: Inspiration Mining Corporation / Key word(s): Miscellaneous

11.01.2018 / 16:00
The issuer is solely responsible for the content of this announcement.


Toronto, Ontario--(Newsfile Corp. - January 11, 2018) - Inspiration Mining Corporation (CSE: ISM) ('Inspiration' or the 'Corporation') is pleased to announce that it has commenced formal negotiations with Compassion Cannabis whereby the Corporation and Compassion Cannabis will enter into some form of a business relationship which will initiate Compassion Cannabis' exposure to the Canadian public markets. One of the options being discussed is the acquisition of all of the issued and outstanding securities of Compassion Cannabis which would result in it becoming a wholly owned subsidiary of the Corporation.

Compassion Cannabis, a private Ontario company, has the expertise to capitalize on the various facets of the going marijuana market, including the 'Vape' market and dispensary centers for the industry. The Corporation is of the opinion that the 'Vape' market and dispensary centers represent an opportunity to capitalize on the growing medical cannabis industry.

Inspiration will provide shareholders with updates on the status of its discussions with compassion Cannabis and there can be no assurance that the corporation will enter into any agreement with Compassion Cannabis.

For further information, please contact Randy Miller, Chief Executive Officer of the Corporation, at tel: 416-842-9000, www.inspirationmining.com

The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

This press release contains forward-looking statements based on assumptions, uncertainties and management's best estimates of future events. Actual results may differ materially from those currently anticipated. Investors are cautioned that such forward-looking statements involve risks and uncertainties. Important factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements are detailed from time to time in the Corporation's periodic reports filed with the Ontario Securities Commission and other regulatory authorities. The Corporation has no intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Click on, or paste the following link into your web browser, to view the associated documents http://www.newsfilecorp.com/release/31929


11.01.2018 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de



show this

News im Fokus

Commerzbank baut Privatkundenberatung zu ETFs aus

19. Januar 2018, 14:10

Aktuelle Research-Studie

Sanochemia Pharmazeutika AG

Original-Research: Sanochemia Pharmazeutika AG (von Sphene Capital GmbH): Buy

19. Januar 2018